8/13/2019 SCD.ppt
1/41
8/13/2019 SCD.ppt
2/41
Sudden cardiac death
Sudden cardiac death (SCD) accounts for up to
50% of cardiovascular-related deaths in the
United States and other developed countries.
By definition, SCD refers to the acute and
natural death from cardiac causes within a
short period (often within an hour of onset of
symptoms).
8/13/2019 SCD.ppt
3/41
Sudden cardiac death
The time and mode of death are unexpected,
and often death occurs in patients without
any prior potentially fatal conditions.
Most cases of SCD are associated with
underlying cardiac arrhythmias; however,
other causes have been identified.
8/13/2019 SCD.ppt
4/41
PATHOPHYSIOLOGY AND MECHANISM OF
SUDDEN CARDIAC DEATH
The mechanism of SCD is complex and is often
associated with an interplay between
anatomical substrates, functional substrates,
and transient events that lead to the initiation
of ventricular arrhythmias (VT or VF)
8/13/2019 SCD.ppt
5/41
Causes of sudden cardiac death
Electrophysiologic abnormalities--
Coronary artery disease--
Primary cardiomyopathies--
Myocarditis--
Valvular heart disease-- Arrhythmogenic right ventricular dysplasia--
Pulmonary hypertension--
Hypertensive heart disease--
Congenital heart disease--
Inflammatory and infiltrative disease of myocardium--
Neuromuscular disease--
Intracardiac obstruction--
Acute aortic dissection--
8/13/2019 SCD.ppt
6/41
Interactions of various factors that
cause sudden cardiac death
8/13/2019 SCD.ppt
7/41
8/13/2019 SCD.ppt
8/41
9/99 8
Sudden Cardiac Death
Incidence
400,000 - 500,000/year in U.S.
Only 2% - 15% reach the hospital Half of these die before discharge
High recurrence rate
8/13/2019 SCD.ppt
9/41
9/99 9
Underlying Arrhythmia of Sudden
Death
VT
62%Bradycardia
17%
Torsades
de Pointes
13%
Primary
VF
8%
8/13/2019 SCD.ppt
10/41
9/99 10
ARRHYTHMIC MECHANISM OF SUDDEN
CARDIAC DEATH
In approximately 80 percent of cases, a sustainedventricular arrhythmia is preceded by an increase inventricular ectopy
These spontaneous arrhythmias are present for avariable period of time prior to the development of asustained ventricular tachyarrhythmia
In about one-third of cases, the tachyarrhythmia is
initiated by an early R on T ventricular prematurebeat; in the remaining two-thirds, the arrhythmia is
initiated by a late cycle VPB
8/13/2019 SCD.ppt
11/41
9/99 11
ARRHYTHMIC MECHANISM OF SUDDEN
CARDIAC DEATH
A bradyarrhythmia or asystole is an important
but less common cause of SCD, being
observed in only about 10 percent of cases
A bradyarrhythmia is more often associated
with a nonischemic cardiomyopathy
8/13/2019 SCD.ppt
12/41
9/99 12
ETIOLOGY OF SUDDEN CARDIAC DEATH
There are many cardiac and noncardiac causes for a
sustained ventricular tachyarrhythmia that can result
in SCD
In one study of 809 patients with a cardiac arrest, 34percent had a noncardiac origin, most commonly due
to trauma, nontraumatic bleeding, intoxication, near
drowning, or pulmonary embolism
8/13/2019 SCD.ppt
13/41
8/13/2019 SCD.ppt
14/41
8/13/2019 SCD.ppt
15/41
8/13/2019 SCD.ppt
16/41
8/13/2019 SCD.ppt
17/41
9/99 17
Clinical Substrates Associated with VF
Arrest
Myocardial ischemia and infarction
Acute myocardial infarction is associated with an
approximate 15% risk of VF within the first 24 to
48 hours, with the incidence falling to only 3percent over the next several days
When VF is provoked by an AMI, symptoms of the
infarction are present for minutes to hours before
sudden death occurs; over 80 percent of VF
episodes occur within the first 6 hours
8/13/2019 SCD.ppt
18/41
9/99 18
Clinical Substrates Associated with
VF Arrest
Congestive heart failure
The presence of CHF increases overall mortality
and the incidence of SCD in both men and women
8/13/2019 SCD.ppt
19/41
9/99 19
CHF Predict Increased Sudden Death and Overall
Mortality
During a 38 years follow-up of subjects in the Framingham
Heart Study, the presence of CHF significantly increased
sudden death and overall mortality in both men andwomen. *P
8/13/2019 SCD.ppt
20/41
9/99 20
Risk of Sudden Death: Data from GISSI-2 Trial
Patients withoutLV Dysfunction
Patients with
LV DysfunctionNo PVBs
1-10 PVBs/h
> 10 PVBs/h
0.86
A
0.88
0.90
0.92
0.94
0.96
0.98
1.00
0 30 60 90 120 150 180
Days
Sur
vival
p log-rank 0.002
0.88
0.90
0.92
0.94
0.96
0.98
1.00
0 30 60 90 120 150 180
Days
Sur
vival
B
p log-rank
0.0001
0.86
8/13/2019 SCD.ppt
21/41
9/99 21
Clinical Substrates Associated with
VF Arrest
Left ventricular hypertrophy
Hypertension with LVH appears to increase the risk of
SCD
In one study, patients with hypertension and LVH whodied suddenly had less extensive coronary disease
than normotensives who had SCD
These findings suggest that the hypertrophied
myocardium is more susceptible than normalmyocardium to the the effects of ischemia
8/13/2019 SCD.ppt
22/41
9/99 22
Clinical Substrates Associated with VF Arrest
Absence of structural heart disease (primary electrical
disease) Rarely, SCD occurs in patients younger than 40 years of
age who have no evidence of structural heart disease
However, in approximately 90 percent of these casesautopsy reveals evidence of underlying heart diseasethat was unrecognized, including myocarditis,hypertrophic cardiomyopathy, arrhythmogenic RVdysplasia, sarcoidosis, or asymptomatic coronary heart
disease The remaining 10 percent of patients have idiopathic
ventricular fibrillation ("primary electrical disease)
8/13/2019 SCD.ppt
23/41
9/99 23
Clinical Substrates Associated with VF
Arrest
Myocardial ischemia and infarction
Acute myocardial infarction is associated with an
approximate 15% risk of VF within the first 24 to
48 hours, with the incidence falling to only 3percent over the next several days
When VF is provoked by an AMI, symptoms of the
infarction are present for minutes to hours before
sudden death occurs; over 80 percent of VF
episodes occur within the first 6 hours
8/13/2019 SCD.ppt
24/41
9/99 24
Clinical Substrates Associated with VF Arrest
Brugada's syndrome One interesting subgroup are patients with
Brugada's syndrome who have a peculiar ECGpattern consisting of a RBBB and ST segment
elevation in V1 to V3 One study reported data on 63 such patients, 41 of
whom were diagnosed after an episode of SCD
During a 34 month follow-up, a recurrent
arrhythmic event occurred in 34 percent ofsymptomatic patients and in 27 percent ofasymptomatic patients
8/13/2019 SCD.ppt
25/41
9/99 25
Clinical Substrates Associated with VF Arrest
Commotio cordis
Sudden death has been described in young athletes
who have been struck in the precordium with a
projectile object such as a baseball, hockey puck, orfist
One study described an animal model in which low-
energy blows to the chest wall delivered during
repolarization, just before the peak of the T wave,produced ventricular fibrillation
8/13/2019 SCD.ppt
26/41
8/13/2019 SCD.ppt
27/41
9/99 27
OUTCOME OF RESUSCITATION
When the initial rhythm is asystole, the likelihood of
successful resuscitation is low and, when performed out
of hospital, less than 10 percent survive to hospitalization
The outcome is much better when the initial rhythm is a
sustained VT (65 to 70% survival)
Approximately 25 percent of patients with VF survive to
be discharged; in the majority of these patients an acute
myocardial infarction is the underlying mechanism
Patients who have SCD due to PEA also have a pooroutcome
8/13/2019 SCD.ppt
28/41
9/99 28
FACTORS RELATED TO THE OUTCOME OF
RESUSCITATION
The only effective way to reestablish organized
electrical activity and myocardial contraction is
prompt electrical defibrillation
It has been estimated that organ damage becomesirreversible after approximately 4 minutes of VF
As a result, the longer the duration of the cardiac
arrest, the lower the likelihood of resuscitation or
survival even if initial resuscitation is successful
8/13/2019 SCD.ppt
29/41
9/99 29
FACTORS RELATED TO THE OUTCOME OF
RESUSCITATION
The Seattle Heart Watch program has reported onthe outcome of patients resuscitated at the scene bya bystander trained in CPR compared with CPRinitiated by emergency medical personnel
There was no difference in the percentage ofpatients resuscitated at the scene and admitted aliveto the hospital (67 versus 61 percent)
However, the percentage discharged alive wassignificantly higher among those with bystander-initiated CPR (43 versus 22 percent, p< 0.001)
8/13/2019 SCD.ppt
30/41
9/99 30
Bystander-initiated CPR ImprovesOutcome
8/13/2019 SCD.ppt
31/41
8/13/2019 SCD.ppt
32/41
9/99 32
FACTORS RELATED TO THE OUTCOME OF
RESUSCITATION
In addition to later onset of CPR, there are a
number of other factors that are associated with
a poor outcome with CPR Cancer or Alzheimer's
disease
History of >2 chronic
diseases A history of cardiac
disease
Absence of any vital signs
Sepsis
An initial rhythm of asystole or
PEA
CPR lasting >5 minutes CVA with severe neurologic
deficit
8/13/2019 SCD.ppt
33/41
9/99 33
PROVOKING FACTORS
Electrolyte disturbances
Any reversible metabolic abnormalities should be
identified and corrected, particularly hypokalemia
and hypomagnesemia which may predispose toventricular tachyarrhythmias
Antiarrhythmic drugs
Whenever possible, antiarrhythmic drugs should
be discontinued prior to any diagnostic studies
8/13/2019 SCD.ppt
34/41
9/99 34
PROVOKING FACTORS
Use of anillicit drugsuch as cocaine can
directly cause arrhythmia or produce coronary
artery vasospasm and ischemia
Aprolonged QTinterval which may be
acquired (due, for example, to a drug or
electrolyte disturbance) or inherited
8/13/2019 SCD.ppt
35/41
9/99 35
CARDIAC EVALUATION
It is essential that the patient undergo a completecardiac examination to establish the nature and
extent of underlying heart disease
The LV function and coronary anatomy should be
assessed utilizing physical examination, echo, cardiac
catheterization, and, if warranted, myocardial biopsy
Since global LV dysfunction due to myocardial
stunning may be present as a result of the cardiac
arrest, baseline evaluation of left ventricular function
should be performed at least 48 hours after
resuscitation
8/13/2019 SCD.ppt
36/41
9/99 36
ARRHYTHMIA EVALUATION
There are different approaches (termed
conservative and aggressive) to the evaluation
and treatment of SCD
Ongoing controlled trials may in the future
provide information as to which of these
approaches is associated with the best
outcome
8/13/2019 SCD.ppt
37/41
9/99 37
Conservative approach
The conservative approach involves a complete
arrhythmia evaluation to establish at baseline the
type, frequency, and reproducibility of spontaneous
ventricular ectopy, and the inducibility of aventricular tachyarrhythmia
This involves the use of noninvasive ambulatory
monitoring for 48 hours, an exercise test, and an
invasive electrophysiologic study
8/13/2019 SCD.ppt
38/41
9/99 38
Conservative approach
For patients with SCD, in whom sustained
monomorphic VT is induced at baseline, the use of
antiarrhythmic agents to prevent the induction of
sustained VT may be an adequate and effective firstapproach
For those patients who have recurrent arrhythmia,
the ICD could be considered as an additional or
alternative therapy
8/13/2019 SCD.ppt
39/41
9/99 39
Aggressive approach
The aggressive approach uses the ICD in all
victims of SCD whose chance of recurrence with
therapy cannot be accurately predicted
High, medium and low risk are all objective, sincerecurrence of ventricular fibrillation is often
lethal
8/13/2019 SCD.ppt
40/41
9/99 40
Aggressive approach
When using an aggressive approach, the value of
diagnostic testing is to find conditions that do not
require ICD insertion, like episodic prolonged sinus
arrest, severe AV nodal or infranodal disease causingintermittent third degree AV block, and preexcitation
with AF leading to VF
These and some other arrhythmias should be treated
with pacemaker, radiofrequency ablation ortherapies other than ICD
8/13/2019 SCD.ppt
41/41